Home » Bayer to Bring Five Drug Candidates Into Late-Stage Clinical Studies By 2015
Bayer to Bring Five Drug Candidates Into Late-Stage Clinical Studies By 2015
Bayer is planning to speed up the development of drugs currently undergoing Phase I and II clinical trials. The drugmaker wants the drugs, for oncology, women’s health and cardiology, in Phase III trials by 2015.
Nasdaq
Nasdaq
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May